What does MEDICIM do?

MEDICIM is an IT company in Mechelen. Public Limited, started on 21 November 2002, 1 establishment.

What is the address of MEDICIM?

The registered office of MEDICIM is located at Stationsstraat 102-108, 2800 Mechelen.

Is MEDICIM still active?

Yes. According to the CBE (31 October 2026) MEDICIM is active, legal situation “Normale toestand”, started on 21 November 2002.

Is MEDICIM registered on Peppol?

Yes, MEDICIM is registered on the Peppol network with ID 0208:0478823474.

What is the enterprise number of MEDICIM?

The enterprise number of MEDICIM is BE0478823474.

When was MEDICIM founded?

MEDICIM was founded on 21 November 2002.

Who are the directors of MEDICIM?

According to the 2025 annual accounts, the directors of MEDICIM are: Wesley Menten, Adrian Schell, Filip Schutyser.

Is MEDICIM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 November 2002; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did MEDICIM make in 2025?

MEDICIM recorded a loss after taxes of € 5,250,797 in financial year 2025.

What is the revenue of MEDICIM?

In its most recent annual accounts (2025), MEDICIM reported revenue of € 18,629,794.

How much does an employee at MEDICIM earn?

The average wage cost per full-time employee at MEDICIM was € 131,800 in 2025: staff costs of € 14.1 million for 107.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDICIM have?

According to the 2025 annual accounts, MEDICIM has 107.2 full-time equivalents (FTE).

MEDICIM (Public Limited) - Mechelen - BE0478823474

Dossier MEDICIM, printed on 1 November 2026 from databakkes.be/en/0478823474/medicim. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 1 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 51 % of short-term debt in 2025; threshold 65 %.
Shrinking team NBB

FTE fell two years in a row, from 128.5 to 107.2.

Financials

Financial year 2025

MEDICIM from Mechelen, company number BE0478823474, closed financial year 2025 with a result of € -5.3 million after tax. For that financial year MEDICIM recorded revenue of € 18.6 million and equity of € -3.8 million. Compared with financial year 2024, the result moved from € -947,763 to € -5.3 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Caution

€ -3.8 million

▼ € 5.2 million vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5.3 million

▼ 454 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 78

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -4.9 million.

People and assets in 2025

Full-time equivalents

107.2

▼ 4.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 14.1 million

▲ 2% vs 2024

€ 131,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 152,815

▲ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 27.8 million

▲ 10% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 557,535

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 67 days on average.

Taxes and wages

€ 2.9 million

▲ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 15,896,929 Revenue 2022: € 15,896,929 First fiscal year in the series	€ 17,103,317 Revenue 2023: € 17,103,317 ▲ 8% vs 2022 (€ 15,896,929) Favourable step	€ 19,553,286 Revenue 2024: € 19,553,286 ▲ 14% vs 2023 (€ 17,103,317) Favourable step	€ 18,629,794 Revenue 2025: € 18,629,794 ▼ 5% vs 2024 (€ 19,553,286) Unfavourable step	▼ 5%
Profit after taxes	€ -1,026,401 Profit after taxes 2022: € -1,026,401 First fiscal year in the series	€ -2,400,478 Profit after taxes 2023: € -2,400,478 ▼ € 1.4 million vs 2022 (€ -1,026,401) Unfavourable step	€ -947,763 Profit after taxes 2024: € -947,763 ▲ € 1.5 million vs 2023 (€ -2,400,478) Favourable step	€ -5,250,797 Profit after taxes 2025: € -5,250,797 ▼ € 4.3 million vs 2024 (€ -947,763) Unfavourable step	▼ € 4.3 million
Equity	€ 4,724,718 Equity 2022: € 4,724,718 First fiscal year in the series	€ 2,324,240 Equity 2023: € 2,324,240 ▼ 51% vs 2022 (€ 4,724,718) Unfavourable step	€ 1,376,477 Equity 2024: € 1,376,477 ▼ 41% vs 2023 (€ 2,324,240) Unfavourable step	€ -3,838,320 Equity 2025: € -3,838,320 ▼ € 5.2 million vs 2024 (€ 1,376,477) Unfavourable step	▼ € 5.2 million
Total debts	€ 28,917,290 Total debts 2022: € 28,917,290 First fiscal year in the series	€ 30,786,938 Total debts 2023: € 30,786,938 ▲ 6% vs 2022 (€ 28,917,290) Unfavourable step	€ 29,254,872 Total debts 2024: € 29,254,872 ▼ 5% vs 2023 (€ 30,786,938) Favourable step	€ 31,669,779 Total debts 2025: € 31,669,779 ▲ 8% vs 2024 (€ 29,254,872) Unfavourable step	▲ 8%
Cash	€ 19 Cash 2022: € 19 First fiscal year in the series	€ 10 Cash 2023: € 10 ▼ 49% vs 2022 (€ 19) Unfavourable step	€ 78 Cash 2024: € 78 ▲ € 68 vs 2023 (€ 10) Favourable step	€ 78 Cash 2025: € 78 Unchanged (€ 78) Unchanged
Retained profit	€ 3,695,138 Retained profit 2022: € 3,695,138 First fiscal year in the series	€ 1,294,661 Retained profit 2023: € 1,294,661 ▼ 65% vs 2022 (€ 3,695,138) Unfavourable step	€ 346,897 Retained profit 2024: € 346,897 ▼ 73% vs 2023 (€ 1,294,661) Unfavourable step	€ -4,903,900 Retained profit 2025: € -4,903,900 ▼ € 5.3 million vs 2024 (€ 346,897) Unfavourable step	▼ € 5.3 million
Bank debt	€ 24,602,753 Bank debt 2022: € 24,602,753 First fiscal year in the series	€ 27,586,060 Bank debt 2023: € 27,586,060 ▲ 12% vs 2022 (€ 24,602,753) Unfavourable step	€ 25,222,993 Bank debt 2024: € 25,222,993 ▼ 9% vs 2023 (€ 27,586,060) Favourable step	€ 27,793,193 Bank debt 2025: € 27,793,193 ▲ 10% vs 2024 (€ 25,222,993) Unfavourable step	▲ 10%
Balance sheet total	€ 33,642,007 Balance sheet total 2022: € 33,642,007 First fiscal year in the series	€ 33,111,179 Balance sheet total 2023: € 33,111,179 ▼ 2% vs 2022 (€ 33,642,007) Unchanged	€ 30,631,349 Balance sheet total 2024: € 30,631,349 ▼ 7% vs 2023 (€ 33,111,179) Unchanged	€ 27,831,459 Balance sheet total 2025: € 27,831,459 ▼ 9% vs 2024 (€ 30,631,349) Unchanged	▼ 9%
Employees (FTE)	135 Employees (FTE) 2022: 135 First fiscal year in the series	128.5 Employees (FTE) 2023: 128.5 ▼ 6.5 vs 2022 (135) Unchanged	112 Employees (FTE) 2024: 112 ▼ 16.5 vs 2023 (128.5) Unchanged	107.2 Employees (FTE) 2025: 107.2 ▼ 4.8 vs 2024 (112) Unchanged	▼ 4.8

Key figures of MEDICIM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICIM?

What happened at MEDICIM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Wesley Menten stepped down as director. NBB
2028 Adrian Schell stepped down as director. NBB
2028 Filip Schutyser stepped down as director. NBB
Jul 10, 2026 New annual accounts for financial year 2025: loss of € 5.3 million. Source: NBB ↗
2023 Wesley Menten became a director. NBB
2023 Adrian Schell became a director. NBB
2017 Filip Schutyser became a director. NBB
Oct 1, 2006 New establishment in Mechelen. KBO

In short

From € 1 million loss in 2022 to € 5.3 million loss in 2025.

Paid € 190,867 in corporate taxes since 2022.

Pays suppliers within 67 days on average.

Original PDFs at the National Bank ↗

Management

MEDICIM

Circle Anatoscope Intuitive Design 20%

It owns 20% of Circle Anatoscope Intuitive Design itself.

Directors

According to the 2025 annual accounts

Wesley Menten

bestuurder

since 2023 · until 2028

Adrian Schell

bestuurder

since 2023 · until 2028

Filip Schutyser

bestuurder

since 2017 · until 2028

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 102-108

2800 Mechelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Grand Opticiens Belgium

€ 154.7 million revenue · 2025

BRUNEL BELGIUM

€ 15.9 million revenue · 2025

NOBEL BIOCARE BELGIUM

€ 25.9 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0478.823.474

VAT number

BE 0478.823.474

Registered office

Stationsstraat 102-108, 2800 Mechelen

Names & denominations

MEDICIM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

21 November 2002

Peppol

Active · Active since 29 Dec 2025

Activities · NACE

Ontwerpen van computerprogramma’s

Overige advisering in verband met programmatuur en levering van programmatuur

Ontwerpen en programmeren van computerprogramma's

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICIM

Warning lights

Financials

What happened to MEDICIM?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions